AmideBio consolidates to Louisville

LOUISVILLE – Biotechnology company AmideBio LLC has consolidated its offices and moved to a laboratory facility in the Colorado Technology Center in Louisville to prepare for future growth.

Company employees will focus on making peptide products at the new location, AmideBio said in a statement. Peptides are biological substances, which can be used in Alzheimer’s research, among other things. The company previously had locations in Boulder and Denver.

“This will allow us to scale up production, and will also provide adequate space for future expansion,” Misha Plam, co-founder of the company, said in the press statement.

Broker Geoffrey Keys of Keys Commercial Real Estate, represented AmideBio in the lease transaction. AmideBio’s new facility at 331 South 104 St. in Louisville is the former location of Inverness Medical Biostar Inc.

AmideBio products are made under license with technology invented at the University of Colorado at Boulder. The company’s manufacturing technology lowers the cost of making peptides, which may lead to shorter development and manufacturing time in the future for clinical and therapeutic products, the company said.

The peptide manufacturing technology also minimizes toxicity, making it more environmentally sustainable, the company said. AmideBio in May announced that it had received $575,000 in new equity funding from a group of private investors.

on Facebook on LinkedIn